Skip to main content
. Author manuscript; available in PMC: 2023 Jun 14.
Published in final edited form as: Sex Transm Dis. 2021 Dec 1;48(12):S104–S110. doi: 10.1097/OLQ.0000000000001554

Figure 1.

Figure 1.

Percent of urogenital Neisseria gonorrhoeae isolates with reduced antimicrobial susceptibility by site, gender, and gender of sex partner among cisgender males and females, SURRG, 2018 to 2019. AZM nonsusceptible (NS) MIC ≥2.0 μg/mL, TET-R MIC ≥2.0 μg/mL, CIPRO-R MIC ≥1.0 μg/mL, and PCN-R MIC≥2.0 μg/mL. Ceftriaxone and cefixime resistance is not included in the figure because for all 3 SURRG sites and in all genders, cephalosporin (ceftriaxone and cefixime) reduced susceptibility was low (<0.5%).